Experienced in Dysferlinopathy

Dr. Hoda Abdel

Neurology
UPMC Children's Hospital Of Pittsburgh
4401 Penn Ave, 
Pittsburgh, PA 
Experienced in Dysferlinopathy
UPMC Children's Hospital Of Pittsburgh
4401 Penn Ave, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hoda Abdel is a Neurologist in Pittsburgh, Pennsylvania. Dr. Abdel is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Cramp-Fasciculation Syndrome, and Nemaline Myopathy.

Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Pediatrics in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 8 Less Insurance Carriers -

Locations

UPMC Children's Hospital of Pittsburgh
4401 Penn Ave, Pittsburgh, PA 15224
Call: 412-692-5325

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Tideglusib
Study Phase: Phase 2/Phase 3
A Phase 2, Two-Part, Multiple-Ascending-Dose Study of SRP-5051 for Dose Determination, Then Dose Expansion, in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
A Phase 2, Two-Part, Multiple-Ascending-Dose Study of SRP-5051 for Dose Determination, Then Dose Expansion, in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
Enrollment Status: Terminated
Publish Date: March 10, 2025
Intervention Type: Drug
Study Drug: SRP-5051 Exon 51-Skipping Treatment
Study Phase: Phase 2
An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051
An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: SRP-5051
Study Phase: Phase 1/Phase 2
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Enrollment Status: Terminated
Publish Date: August 27, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 2
Pilot Study of Cough Peak Flow And Airway Clearance in Pediatric Patients With Neuromuscular Disease
Pilot Study of Cough Peak Flow And Airway Clearance in Pediatric Patients With Neuromuscular Disease
Enrollment Status: Completed
Publish Date: February 05, 2024
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Phase 1 Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Treatment
A Phase 1 Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Treatment
Enrollment Status: Completed
Publish Date: July 06, 2022
Intervention Type: Drug
Study Phase: Phase 1
An Open-Label Study to Evaluate the Safety of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy
An Open-Label Study to Evaluate the Safety of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy
Enrollment Status: Terminated
Publish Date: May 17, 2021
Intervention Type: Drug
Study Phase: Phase 4
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

24 Total Publications

Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy.
Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy.
Journal: Scientific reports
Published: March 11, 2022
View All 24 Publications
Similar Doctors
Experienced in Dysferlinopathy
Dr. George Small
Neurology
Experienced in Dysferlinopathy
Dr. George Small
Neurology

Allegheny General Hospital

320 E North Ave, 
Pittsburgh, PA 
 (2.7 miles away)
412-359-8850
Languages Spoken:
English
See accepted insurances
Offers Telehealth

George Small is a Neurologist in Pittsburgh, Pennsylvania. Dr. Small is rated as an Advanced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Myasthenia Gravis, Peripheral Neuropathy, Stiff Person Syndrome, and Dysferlinopathy.

Fang J. Sun
Experienced in Dysferlinopathy
Dr. Fang J. Sun
Neurology
Experienced in Dysferlinopathy
Dr. Fang J. Sun
Neurology

UPMC Department Of Neurology

3471 5th Avenue, Suite 810, 
Pittsburgh, PA 
 (1.6 miles away)
412-946-2402
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Fang Sun, MD, specializes in neurology and practices with University of Pittsburgh Physicians, Department of Neurology. Dr. Sun completed her medical education China Medical University and is board certified in Neuromuscular Medicine by the American Board of Psychiatry and Neurology. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Myasthenia Gravis, Facioscapulohumeral Muscular Dystrophy (FSHD), Peripheral Neuropathy, and Dysferlinopathy.

Gurmeet Singh
Experienced in Dysferlinopathy
Dr. Gurmeet Singh
Neurology
Experienced in Dysferlinopathy
Dr. Gurmeet Singh
Neurology

Trinity Health St. Clairsville

109 Plaza Drive, 
St. Clairsville, OH 
 (57.2 miles away)
740-526-0731
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gurmeet Singh is a Neurologist in St. Clairsville, Ohio. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Seizures, Migraine, Memory Loss, and Tension Headache. Dr. Singh is currently accepting new patients.

VIEW MORE DYSFERLINOPATHY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Abdel's expertise for a condition
ConditionClose
    • Distinguished
    • Becker Muscular Dystrophy
      Dr. Abdel is
      Distinguished
      . Learn about Becker Muscular Dystrophy.
      See more Becker Muscular Dystrophy experts
    • Duchenne Muscular Dystrophy
      Dr. Abdel is
      Distinguished
      . Learn about Duchenne Muscular Dystrophy.
      See more Duchenne Muscular Dystrophy experts
    • Advanced
    • Cramp-Fasciculation Syndrome
      Dr. Abdel is
      Advanced
      . Learn about Cramp-Fasciculation Syndrome.
      See more Cramp-Fasciculation Syndrome experts
    • Experienced
    • Centronuclear Myopathy
      Dr. Abdel is
      Experienced
      . Learn about Centronuclear Myopathy.
      See more Centronuclear Myopathy experts
    • Congenital Fiber-Type Disproportion
      Dr. Abdel is
      Experienced
      . Learn about Congenital Fiber-Type Disproportion.
      See more Congenital Fiber-Type Disproportion experts
    • Dysferlinopathy
      Dr. Abdel is
      Experienced
      . Learn about Dysferlinopathy.
      See more Dysferlinopathy experts
    • Guillain-Barre Syndrome
      Dr. Abdel is
      Experienced
      . Learn about Guillain-Barre Syndrome.
      See more Guillain-Barre Syndrome experts
    • Nemaline Myopathy
      Dr. Abdel is
      Experienced
      . Learn about Nemaline Myopathy.
      See more Nemaline Myopathy experts
    • Primary Lateral Sclerosis
      Dr. Abdel is
      Experienced
      . Learn about Primary Lateral Sclerosis.
      See more Primary Lateral Sclerosis experts
    View All 13 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.